Chemo prevention for bowel cancer - the prospects and challenges

Share :
Published: 20 Nov 2009
Views: 11808
Prof Richard Logan, Clinical Epidemiology, University of Nottingham, UK
Prof Logan discusses the aspirin and folic acid supplement trial that was published last year. The trial looked at aspirin and folic acid supplements for preventing colorectal adenoma recurrence in people who already had an adenoma removed. The trial showed by taking aspirin there was a risk reduction of about one third in developing a recurrent colorectal adenoma. However Folic acid had no effect.